International Business Machines Corporation

New York Stock Exchange
Back to all articles
Bullish +75

Jim Cramer on IBM: “I Think the Buy on This Mild Pullback Is The Right Thing to Do” - Yahoo Finance

🤖 Jim Cramer advises buying IBM on its recent stock pullback, viewing the decline as a buying opportunity for investors.

📉 IBM's shares have declined post-earnings due to market skepticism regarding legacy software and concerns over near-term monetization.

🔮 The company is positioned for future growth through significant investments in quantum computing and AI innovation.

🤝 IBM is partnering with Arm Holdings to develop dual-architecture chips specifically for enterprise AI workloads.

💰 Despite the stock decline, IBM trades at 18.6x forward P/E, which Cramer considers obscenely cheap for a firm with such ambitions.

⚙️ Investors fear that legacy software could drag on performance, though Cramer believes new innovations will eventually outweigh this drag.

🚀 Cramer views IBM as a misunderstood innovator that may be released from the "penalty box" sooner rather than later.

📉 Concerns about AI cannibalizing parts of the business and potential growth stagnation continue to weigh on the stock's current valuation.

🔬 Quantum research efforts are seen as long-term value drivers, similar to how early investors were skeptical of AI before ChatGPT.

💊 IBM is expected to pivot from simulating magnetic materials toward game-changing applications like AI- and quantum-assisted biotech.

🤝 Strategic partnerships and collaborations are viewed as win-win opportunities that could enhance IBM's impact in the AI space.

📈 Historical performance suggests IBM has staying power, even as it navigates the transition to more modern tech-focused models.

Bullish Signals
  • IBM is partnering with Arm Holdings (ARM) on dual-architecture chips for enterprise AI workloads, positioning it for collaborative growth.
  • Despite the stock trading at 18.6x forward P/E, IBM has strong staying power in software, ambitious AI initiatives, and a promising quantum business that may be undervalued.
  • Strategic partnerships and research investments in frontier technologies like quantum computing could drive future upside surprises as these nascent technologies mature.
  • Management views the stock as potentially misunderstood and could see it leave the 'penalty box' sooner rather than later as AI-native innovations take off.
  • Long-term potential exists to shift focus from legacy operations toward more profitable future innovations in agentic AI, biotech applications, and quantum computing.
Risk Factors
  • IBM's post-earnings stock decline reflects market skepticism about legacy software drag and near-term monetization.
  • Worries persist about AI's potential to cannibalize parts of the business, leading investors to favor hotter semiconductor plays instead.
  • Concerns exist that growth could stall out despite in-line guidance, causing shares to be left out of the latest AI investment party.
  • The stock faces challenges valuing futuristic innovation while carrying the weight of legacy systems and software issues.
  • Quantum research efforts probably won't be immediately monetizable enough to cause vicious price surges seen elsewhere.
  • The company is due to run into a tougher period as the rest of the market rallies higher, potentially underperforming peers.
Full Analysis
Jim Cramer, the host of Mad Money on CNBC and an influential voice in financial media, expressed bullish sentiment regarding International Business Machines (NYSE:IBM) following a recent pullback in its stock price. Speaking via Yahoo Finance, Cramer noted that IBM is partnering with Arm Holdings (NASDAQ:ARM) to develop dual-architecture chips designed for enterprise AI workloads, a strategic move he views as a significant win for both firms. Despite the company reporting earnings that technically beat expectations but failed to impress investors due to concerns about legacy software dragging down growth, Cramer argues that the stock remains "obscenely cheap" at 18.6 times forward price-to-earnings (P/E). He contends that this valuation offers a compelling buying opportunity, particularly given IBM's substantial investments in research and development for quantum computing and artificial intelligence innovation that could drive future upside surprises as these nascent technologies mature. Cramer acknowledges the market skepticism surrounding IBM's legacy software segment and the potential for AI to cannibalize certain parts of its traditional business, such as COBOL-related workloads. However, he maintains that the net effect of integrating new innovations like agentic AI and quantum computing will ultimately be positive over the long run. He compares IBM's current situation to how the market previously undervalued AI potential before the arrival of ChatGPT several years ago, suggesting investors may be similarly discounting the transformative power of the company's frontier research efforts. While some competitors in the semiconductor sector have experienced recent rallies that heat up investor attention, Cramer believes IBM is worth holding through a tougher period because its breakthroughs from quantum and AI research are not going to be for nothing, especially as applications evolve from intriguing concepts like simulating magnetic materials to game-changing uses such as AI- and quantum-assisted biotech for drug discovery. The analyst further suggests that while the software side of IBM faces uncertainty and question marks regarding monetization timelines, the company is becoming a more misunderstood innovator rather than just a legacy play. He views the partnership with Arm Holdings and similar collaborative deals among major AI heavyweights as "win-win" arrangements that could allow IBM to make bigger splashes in enterprise AI. While acknowledging that quantum efforts may not generate immediate, vicious melt-ups like those seen in the semiconductor industry recently, Cramer emphasizes that the stock is positioned for potential re-rating as investors begin to fully appreciate the dual-architecture chips and the firm's shifting focus toward future innovations. Ultimately, he concludes that buying on this mild pullback is the right thing to do, positioning IBM as a company with staying power, AI ambition, and quantum business potential that is currently discounted by the market.